The evidence linking the talc in baby powder to ovarian cancer has been mounting for more than four decades. Lawsuits against Johnson & Johnson (J&J) have proven successful since the first talcum powder trial in 2013, and the number of claims now reaches into the thousands. The healthcare giant successfully obtained dismissal in two New Jersey lawsuits, but the company faces another trial this month in St. Louis.
With more than 200 baby powder lawsuit on file in New Jersey, J&J might consider the recent dismissal a victory, but this is far from the truth. Attorneys for the plaintiffs plan to appeal the court’s ruling, and like other baby powder victims, they aren’t going down without a fight.
Before dismissal, the cases were scheduled to go to trial this October. The company will go to trial in another case this month in St. Louis, where its tactics haven’t been so successful. The second baby powder case to go trial was filed by plaintiff Jacqueline Fox. Although Ms. Fox lost her battle with ovarian cancer, her family was awarded $72 million in damages due to J&J’s gross negligence in its failure to warn.
Just months later, the company lost the third baby powder case to go trial. A St. Louis jury found the company knew about the risks associated with talc, but failed to warn consumers. The plaintiff and her family were awarded $55 million in damages.
These cases only scratch the surface of the talcum powder claims made against the company. Since the landmark verdicts, tens of thousands of claims have surfaced and are being investigated by plaintiffs’ attorneys, and more than 1,000 cases are currently filed against the company. The upcoming September trial will put extreme pressure on the company, and if past trials are any indication, it doesn’t look good for Johnson & Johnson.